Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
QuantumSphere is a nanotechnology company that specialized in the production of high-purity metal and alloy nanoparticles using its proprietary Automated Vapor Condensation (AVC) process. The company's primary healthcare contribution involved the development of "QSI-Nano" silver and copper nanoparticles, which were utilized for their potent antimicrobial properties in medical device coatings and wound care applications. Their technology platform allowed for the creation of highly consistent, non-agglomerated particles with high surface area-to-volume ratios, optimizing biological interaction and efficacy. Despite achieving commercial-scale production and establishing partnerships for its nanomaterials, the company faced financial insolvency and filed for bankruptcy in 2018.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on QuantumSphere.